These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28373298)

  • 1. MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway.
    Couzens AL; Xiong S; Knight JDR; Mao DY; Guettler S; Picaud S; Kurinov I; Filippakopoulos P; Sicheri F; Gingras AC
    Mol Cell Proteomics; 2017 Jun; 16(6):1098-1110. PubMed ID: 28373298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Protein Interactions by
    Xiong S; Couzens AL; Kean MJ; Mao DY; Guettler S; Kurinov I; Gingras AC; Sicheri F
    Mol Cell Proteomics; 2017 Jun; 16(6):1111-1125. PubMed ID: 28373297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for Mob1-dependent activation of the core Mst-Lats kinase cascade in Hippo signaling.
    Ni L; Zheng Y; Hara M; Pan D; Luo X
    Genes Dev; 2015 Jul; 29(13):1416-31. PubMed ID: 26108669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
    Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
    J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinases of the Hippo pathway: regulation and substrates.
    Avruch J; Zhou D; Fitamant J; Bardeesy N; Mou F; Barrufet LR
    Semin Cell Dev Biol; 2012 Sep; 23(7):770-84. PubMed ID: 22898666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control.
    Kulaberoglu Y; Lin K; Holder M; Gai Z; Gomez M; Assefa Shifa B; Mavis M; Hoa L; Sharif AAD; Lujan C; Smith ESJ; Bjedov I; Tapon N; Wu G; Hergovich A
    Nat Commun; 2017 Sep; 8(1):695. PubMed ID: 28947795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and Biochemical Analyses of the Core Components of the Hippo Pathway.
    Ni L; Luo X
    Methods Mol Biol; 2019; 1893():239-256. PubMed ID: 30565138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.
    Couzens AL; Knight JD; Kean MJ; Teo G; Weiss A; Dunham WH; Lin ZY; Bagshaw RD; Sicheri F; Pawson T; Wrana JL; Choi H; Gingras AC
    Sci Signal; 2013 Nov; 6(302):rs15. PubMed ID: 24255178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
    Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
    Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.
    Li C; Srivastava RK; Elmets CA; Afaq F; Athar M
    Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kim E; Kang JG; Kang MJ; Park JH; Kim YJ; Kweon TH; Lee HW; Jho EH; Lee YH; Kim SI; Yi EC; Park HW; Yang WH; Cho JW
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14259-14269. PubMed ID: 32513743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for autoinhibition and its relief of MOB1 in the Hippo pathway.
    Kim SY; Tachioka Y; Mori T; Hakoshima T
    Sci Rep; 2016 Jun; 6():28488. PubMed ID: 27335147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
    Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
    Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP.
    Palamiuc L; Johnson JL; Haratipour Z; Loughran RM; Choi WJ; Arora GK; Tieu V; Ly K; Llorente A; Crabtree S; Wong JCY; Ravi A; Wiederhold T; Murad R; Blind RD; Emerling BM
    Sci Signal; 2024 May; 17(838):eado6266. PubMed ID: 38805583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.
    Vahid S; Thaper D; Gibson KF; Bishop JL; Zoubeidi A
    Sci Rep; 2016 Aug; 6():31842. PubMed ID: 27555231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo Signaling in Mitosis: An Updated View in Light of the MEN Pathway.
    Hergovich A
    Methods Mol Biol; 2017; 1505():265-277. PubMed ID: 27826870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.